Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Joint Bone Spine
Volume 79, n° 2
page 207 (mars 2012)
Doi : 10.1016/j.jbspin.2011.10.009
accepted : 21 October 2011
Correspondence

Change of bone mineral density and treatment of ankylosing spondylitis. Comment to the article of Kang KY et al. “The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis” Joint Bone Spine 2011;78:188–93
 

Daniel Wendling a, , Clément Prati a, Éric Toussirot b, Gilles Dumoulin c
a Service de rhumatologie, université de Franche-Comté, CHU de Besançon, boulevard Fleming, 25030 Besançon, France 
b CIC-BT, université de Franche-Comté, CHU de Besançon, 25030 Besançon, France 
c Explorations fonctionnelles rénales et métaboliques, université de Franche-Comté, CHU de Besançon, 25030 Besançon, France 

Corresponding author.

Keywords : Ankylosing spondylitis, Bone mass, Adipokines, Body composition, Anti-TNF agents




© 2011  Société française de rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline